Adverse cutaneous drug reactions to cardiovascular drugs
https://libcat.nshealth.ca/en/permalink/provcat33470
Esen Özkaya, Kurtulus Didem Yazganoglu.
--London:
Springer
, c2014.
- Available Online
- View e-Book
- Location
- Online
This book describes adverse cutaneous drug reactions as among the most frequent events in patients receiving drug therapy. Cardiovascular drugs are an important group as there are a greater number of indications for the use of new drugs and their prescription continues to increase. The exact incidence of cutaneous side effects from cardiovascular drugs is difficult to estimate due to sporadic reporting. Moreover, a reliable connection between a certain drug and a certain type of reaction can on…
- Available Online
- View e-Book
- Author
- Özkaya, Esen
- Other Authors
- Yazganoglu, K. Didem
- Responsibility
- Esen Özkaya, Kurtulus Didem Yazganoglu
- Place of Publication
- London
- Publisher
- Springer
- Date of Publication
- c2014
- Physical Description
- 1 online resource (xxi, 259 pages)
- ISBN
- 9781447165361 (electronic bk.)
- 9781447165354
- Subjects (LCSH)
- Cardiovascular agents - Side effects
- Dermatopharmacology
- Dermatology
- Cardiology
- Abstract
- This book describes adverse cutaneous drug reactions as among the most frequent events in patients receiving drug therapy. Cardiovascular drugs are an important group as there are a greater number of indications for the use of new drugs and their prescription continues to increase. The exact incidence of cutaneous side effects from cardiovascular drugs is difficult to estimate due to sporadic reporting. Moreover, a reliable connection between a certain drug and a certain type of reaction can only rarely be made, aside from the well-known angioedema/urticaria from angiotensin-converting enzyme inhibitors, lichen planus/lichenoid reaction from beta adrenergic blockers, and photosensitivity from thiazid diuretics. These reactions can extend to rare but life-threatening conditions such as erythroderma, Stevens-Johnson syndrome, toxic epidermal necrolysis and drug hypersensitivity syndrome. Adverse Cutaneous Drug Reactions To Cardiovascular Drugs reviews the reported types of reactions to cardiovascular drugs. Each is discussed according to drug class and the type of dermatologic reaction with special emphasize on cross-reactions and the role of patch testing in diagnosis. A total of 116 images are included featuring clinical appearance of common adverse cutaneous drug reactions and diagnostic procedures such as patch and photopatch testing with the suspected drugs. Complementary tables may allow to scan the most common cutaneous reactions and the related cardiovascular drugs along with the possible cross reactions at first glance. It will thus be of considerable importance to all dermatologists and medical professionals who manage the skin, while being an important reference resource for cardiologists in terms of identifying potential adverse reactions to the drugs they prescribe..
- Contents
- Part I. General Aspects of Adverse Cutaneous Drug Reactions -- 1. General Aspects of Adverse Cutaneous Drug Reactions -- Part II. Adverse Cutaneous Drug Reactions to Specific Class of Cardiovascular Drugs -- 2. Angiotensin-Converting Enzyme Inhibitors -- 3. Angiotensin II Receptor Blockers -- 4. Alpha-2 Adrenergic Receptor Agonists -- 5. Class I Antiarrhythmic Drugs -- 6. Beta Adrenergic Receptor Blockers (Class II Antiarrhythmics) -- 7. Class III Antiarrhythmic Drugs -- 8. Calcium Channel Blockers -- 9. Diuretics -- 10. Vasodilatory Drugs -- 11. Lipid-Lowering Drugs -- 12. Platelet Inhibitors -- 13. Thrombolytics -- 14. Anticoagulants -- 15. Other Cardiovascular Drugs -- Part III. Patch Testing in Drug Eruptions -- 16. Patch Testing in Drug Eruptions.
- Format
- e-Book
- Location
- Online
Comprehensive dermatologic drug therapy
https://libcat.nshealth.ca/en/permalink/provcat32074
[edited by] Stephen E. Wolverton.
(4th ed.)
--Philadelphia, PA:
Elsevier
, c2021.
- Available Online
- View e-Book
- Access
- Registration required for PDF access.
- Location
- Online
Designed with practical usability in mind, Comprehensive Dermatologic Drug Therapy, 4th Edition, helps you safely and effectively treat the skin disorders you’re likely to see in your practice. Dr. Stephen E. Wolverton and new associate editor Dr. Jashin J. Wu lead a team of global experts to bring you concise, complete guidance on today's full spectrum of topical, intralesional, and systemic drugs. You’ll prescribe with confidence thanks to expert coverage of which drugs to use, when to use t…
- Available Online
- View e-Book
- Other Authors
- Wolverton, Stephen E.
- Responsibility
- [edited by] Stephen E. Wolverton
- Edition
- 4th ed.
- Alternate Title
- Dermatologic drug therapy
- Place of Publication
- Philadelphia, PA
- Publisher
- Elsevier
- Date of Publication
- c2021
- Physical Description
- 1 online resource,1000 p.
- ISBN
- 9780323612111
- Subjects (MeSH)
- Skin Diseases - drug therapy
- Dermatologic Agents - therapeutic use
- Subjects (LCSH)
- Skin Diseases - drug therapy
- Dermatologic Agents - therapeutic use
- Dermatopharmacology
- Specialty
- Dermatology
- Pharmacology
- Abstract
- Designed with practical usability in mind, Comprehensive Dermatologic Drug Therapy, 4th Edition, helps you safely and effectively treat the skin disorders you’re likely to see in your practice. Dr. Stephen E. Wolverton and new associate editor Dr. Jashin J. Wu lead a team of global experts to bring you concise, complete guidance on today's full spectrum of topical, intralesional, and systemic drugs. You’ll prescribe with confidence thanks to expert coverage of which drugs to use, when to use them, and adverse effects to monitor.
- Access
- Registration required for PDF access.
- Format
- e-Book
- Location
- Online
